Tag archive for ‘pneumonia’
MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Thursday, November 26th, 2020

RedHill Biopharma expands manufacturing capacity of Covid-19 drug candidate opaganib in US

RedHill Biopharma has forged partnerships with a couple of US-based manufacturers for large-scale manufacturing of opaganib, its Covid-19 drug candidate. The Israeli biopharma company said that the collaborations More...

By pharmanewsdaily On Sunday, November 8th, 2020

Covid-19 phase 3 trial of lenzilumab : Humanigen announces positive interim results

Humanigen said that lenzilumab has delivered a clinically meaningful impact on the recovery of patients hospitalized with Covid-19, as per the interim data of a phase 3 trial. According to the US biopharma company, More...

By pharmanewsdaily On Monday, July 6th, 2020

Gilead Sciences announces Veklury EU approval for COVID-19 treatment

Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the European Commission as a treatment for SARS-CoV-2 infection, the virus behind COVID-19. According More...

By pharmanewsdaily On Tuesday, June 2nd, 2020

Gilead Covid-19 drug candidate remdesivir delivers desired results in phase 3 trial

Remdesivir clinical trial results : Gilead Sciences said that the phase 3 SIMPLE trial, which has been evaluating the Covid-19 drug candidate remdesivir for the treatment of hospitalized patients with moderate pneumonia More...

By pharmanewsdaily On Tuesday, June 2nd, 2020

Apollo Hospitals to use AI platform from Zebra Med for COVID-19 detection

Zebra Medical Vision (Zebra-Med), an Israel-based deep-learning medical imaging analytics company, said that its software will be deployed by India’s Apollo Hospitals Group to help its doctors in efficient More...

By pharmanewsdaily On Friday, April 3rd, 2020

Incyte to launch ruxolitinib coronavirus clinical trial in US

Ruxolitinib coronavirus clinical trial : Incyte revealed that it is working with the US Food and Drug Administration (FDA) to launch the phase 3 RUXCOVID clinical trial to assess the efficacy and safety of ruxolitinib More...

By pharmanewsdaily On Thursday, April 2nd, 2020

Japan’s Fujifilm to test anti-flu drug Avigan to treat coronavirus

Japan-based Fujifilm has started clinical trials to test the efficacy of Avigan, an anti-flu drug to treat coronavirus patients. Trials done in China suggested that Avigan might play a key role in reducing the recovery More...

By Soujanya Ravi On Saturday, March 28th, 2020

behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal

behold.ai claimed that its artificial intelligence-based red dot algorithm has been shown to have quickly identified chest X-rays from COVID-19 patients as ‘abnormal’. The UK-based healthtech company expects More...

By Soujanya Ravi On Thursday, March 26th, 2020

RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford

RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial. The RECOVERY clinical trial, More...

By pharmanewsdaily On Wednesday, March 25th, 2020

BreathTest-1000 coronavirus screening instrument developed by Astrotech

BreathTest-1000 coronavirus screening instrument : Astrotech said that it is developing the BreathTest-1000 screening instrument for coronavirus (COVID-19) and the associated pneumonia, and also other lung diseases. The More...